N-myristoyltransferase1 and N-myristoyltransferase2 Exhibit Differential Substrate Specificity for HIV-Gag and HIV-Nef

N-myristoyltransferase1 and N-myristoyltransferase2 Exhibit Differential Substrate Specificity for HIV-Gag and HIV-Nef

Bibliographic Details
Main Authors:	Smith Charles, Seaton Kelly
Format:	Article
Language:	English
Published:	BMC 2005-12-01
Series:	Retrovirology

Similar Items

QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
by: Letícia Santos-Garcia, et al.
Published: (2018-09-01)

Inhibition of N‐myristoyltransferase1 affects dengue virus replication
by: San Suwanmanee, et al.
Published: (2019-09-01)

N-myristoyltransferase: A potential novel diagnostic marker for colon cancer
by: DeCoteau John, et al.
Published: (2007-11-01)

N-Myristoyltransferase as a drug target : a (chemical) space odyssey
by: Bell, Andy
Published: (2015)

Design and synthesis of N-Myristoyltransferase inhibitors : a promising treatment for malaria
by: Rackham, Mark
Published: (2012)

Diverse modes of binding in structures of Leishmania majorN-myristoyltransferase with selective inhibitors
by: James A. Brannigan, et al.
Published: (2014-07-01)

N-terminal region of the catalytic domain of human N-myristoyltransferase 1 acts as an inhibitory module.
by: Sujeet Kumar, et al.
Published: (2015-01-01)

The Potential Use of N-Myristoyltransferase as a Biomarker in the Early Diagnosis of Colon Cancer
by: Rajendra K Sharma, et al.
Published: (2011-03-01)

Chemical tools to validate N-myristoyltransferase as a new target in cancer therapy
by: Thinon, Emmanuelle
Published: (2013)

Peptidomimetic approach to the inhibition of N-myristoyltransferase, a promising parasitic drug target
by: Olaleye, Tayo
Published: (2012)

Design and synthesis of inhibitors for N-myristoyltransferase, a promising treatment for parasitic diseases
by: Yu, Zhiyong
Published: (2011)

Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi.
by: Linda J Herrera, et al.
Published: (2016-04-01)

Biochemical Characterization of Bovine Brain Myristoyl-CoA:Protein N-Myristoyltransferase Type 2
by: Ponniah Selvakumar, et al.
Published: (2009-01-01)

Analyzing a potential drug target N-myristoyltransferase of Plasmodium falciparum through in silico approaches
by: Amit Kumar Banerjee, et al.
Published: (2012-01-01)

Genetic validation of Leishmania genes essential for amastigote survival in vivo using N-myristoyltransferase as a model
by: Daniel Paape, et al.
Published: (2020-03-01)

Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
by: Andrew S Bell, et al.
Published: (2012-01-01)

Cellular N-myristoyltransferases play a crucial picornavirus genus-specific role in viral assembly, virion maturation, and infectivity.
by: Irena Corbic Ramljak, et al.
Published: (2018-08-01)

NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle
by: Tatsiana Kosciuk, et al.
Published: (2020-02-01)

A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes.
by: Brendan D Galvin, et al.
Published: (2014-09-01)

N-Myristoyltransferase 2-abhängig induzierbare Myristoylierung von PRS4, p22 und Gai2
by: Dulich, Felix
Published: (2009)

QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human <i>N</i>-Myristoyltransferase (Hs-NMT) Inhibitors
by: Magdi E. A. Zaki, et al.
Published: (2021-03-01)

High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation
by: Cyril Dian, et al.
Published: (2020-02-01)

Structure-function studies of kinetoplastid myristoylCoA : protein N-myristoyltransferase and two substrates, the 'Leishmania' vaccine antigen candidates, HASPA and HASPB
by: Panethymitaki, Chrysoula
Published: (2005)

Identification et clonage de protéines rétiniennes : les phosphospholipases A2 sécrétées et les N-myristoyltransférases
by: Laurin, Marc-André
Published: (2003)

In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases.
by: Ranjit Chauhan, et al.
Published: (2018-01-01)

Association of NMT2 with the acyl-CoA carrier ACBD6 protects the N-myristoyltransferase reaction from palmitoyl-CoA[S]
by: Eric Soupene, et al.
Published: (2016-02-01)

Functional association between the nef gene product and gag-pol region of HIV-1.
by: Ono, Takeshi
Published: (2014)

Characterization of HIV-1 <it>gag</it> and <it>nef</it> in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
by: Tongo Marcel, et al.
Published: (2013-01-01)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
by: Kaleebu P, et al.
Published: (2009-10-01)

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins.
by: Zabrina L Brumme, et al.
Published: (2009-08-01)

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
by: Brumme, Zabrina L., et al.
Published: (2010)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
by: Gloria Omosa-Manyonyi, et al.
Published: (2015-01-01)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
by: Morgado MG, et al.
Published: (2009-10-01)

HIV-1 Nef: at the crossroads
by: Garcia J Victor, et al.
Published: (2008-09-01)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
by: Zembe L, et al.
Published: (2012-09-01)

Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
by: Matilda Chelimo Saina, et al.
Published: (2015-01-01)

Reatividade de linfócitos T de indivíduos infectados pelo HIV-1 contra epitopos GAG e NEF de diferentes subtipos HIV-1
by: Coutinho Junior, Raimundo
Published: (2012)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.
by: Kathryn L Hopkins, et al.
Published: (2014-01-01)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
by: Wagner R, et al.
Published: (2009-10-01)

The Nef activity on HIV-1 infectivity
by: Stéphane eBasmaciogullari, et al.
Published: (2014-05-01)

Cannot write session to /tmp/vufind_sessions/sess_jj3vdoq9ufiao52bp54n28lt5m